| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 41.01B | 39.93B | 36.60B | 30.67B | 30.07B |
| Gross Profit | 10.51B | 9.63B | 8.30B | 6.95B | 7.24B |
| EBITDA | 3.61B | 3.22B | 2.54B | 1.62B | 2.12B |
| Net Income | 2.21B | 1.81B | 1.52B | 803.18M | 1.12B |
Balance Sheet | |||||
| Total Assets | 33.90B | 30.93B | 29.10B | 26.13B | 25.88B |
| Cash, Cash Equivalents and Short-Term Investments | 3.53B | 3.00B | 5.81B | 2.20B | 4.72B |
| Total Debt | 4.10B | 1.86B | 884.68M | 959.69M | 1.24B |
| Total Liabilities | 11.42B | 10.49B | 9.99B | 8.51B | 8.93B |
| Stockholders Equity | 22.48B | 20.45B | 19.11B | 17.63B | 16.95B |
Cash Flow | |||||
| Free Cash Flow | -481.24M | -1.40B | 4.05B | -1.48B | 2.35B |
| Operating Cash Flow | 559.52M | 544.47M | 4.33B | -1.44B | 2.41B |
| Investing Cash Flow | -1.49B | -3.93B | -454.46M | -307.92M | -472.56M |
| Financing Cash Flow | 1.47B | 574.12M | -266.50M | -780.77M | -710.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥16.37B | 3.31 | ― | 4.20% | 3.94% | 3.43% | |
74 Outperform | ¥13.81B | 16.42 | ― | 4.14% | 4.73% | 2.00% | |
68 Neutral | ¥1.64B | -3.54 | ― | 2.23% | -5.52% | 224.82% | |
64 Neutral | ¥15.77B | 7.02 | ― | 2.66% | 2.70% | 24.53% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | ¥26.19B | 23.25 | ― | 2.64% | -1.25% | 0.49% | |
48 Neutral | ¥4.19B | -1.50 | ― | 3.25% | -10.52% | -1094.64% |